These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21393094)

  • 1. Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases.
    Vendrame M; Poduri A; Loddenkemper T; Kluger G; Coppola G; Kothare SV
    Epileptic Disord; 2011 Mar; 13(1):18-21. PubMed ID: 21393094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.
    Wisniewski CS
    Ann Pharmacother; 2010 Apr; 44(4):658-67. PubMed ID: 20233912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with rufinamide in a pediatric population: a single center's experience.
    Vendrame M; Loddenkemper T; Gooty VD; Takeoka M; Rotenberg A; Bergin AM; Eksioglu YZ; Poduri A; Duffy FH; Libenson M; Bourgeois BF; Kothare SV
    Pediatr Neurol; 2010 Sep; 43(3):155-8. PubMed ID: 20691934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam.
    Merdariu D; Delanoë C; Mahfoufi N; Bellavoine V; Auvin S
    Brain Dev; 2013 Feb; 35(2):177-80. PubMed ID: 22521903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: a randomized placebo-controlled trial.
    Brodie MJ; Rosenfeld WE; Vazquez B; Sachdeo R; Perdomo C; Mann A; Arroyo S
    Epilepsia; 2009 Aug; 50(8):1899-909. PubMed ID: 19490053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium bromide for treatment of malignant migrating partial seizures in infancy.
    Ünver O; Incecik F; Dündar H; Kömür M; Ünver A; Okuyaz Ç
    Pediatr Neurol; 2013 Nov; 49(5):355-7. PubMed ID: 23968569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convulsions associated with gastroenteritis in the spectrum of benign focal epilepsies in infancy: 30 cases including four cases with ictal EEG recording.
    Cusmai R; Jocic-Jakubi B; Cantonetti L; Japaridze N; Vigevano F
    Epileptic Disord; 2010 Dec; 12(4):255-61. PubMed ID: 21097391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pronounced microcephaly in a patient with malignant migrating partial seizures in infancy.
    Hahn A; Heckel M; Neubauer BA
    Epileptic Disord; 2007 Mar; 9(1):94-7. PubMed ID: 17307719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the new antiepileptic drug rufinamide on cognitive functions.
    Aldenkamp AP; Alpherts WC
    Epilepsia; 2006 Jul; 47(7):1153-9. PubMed ID: 16886978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiepileptic treatment against clustered seizures in benign partial epilepsy in infancy.
    Okumura A; Kato T; Hayakawa F; Maruyama K; Kubota T; Natsume J; Negoro T; Watanabe K
    Brain Dev; 2006 Oct; 28(9):582-5. PubMed ID: 16730937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam in a neonate with malignant migrating partial seizures.
    Hmaimess G; Kadhim H; Nassogne MC; Bonnier C; van Rijckevorsel K
    Pediatr Neurol; 2006 Jan; 34(1):55-9. PubMed ID: 16376281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of rufinamide in children under four years of age with drug-resistant epilepsies.
    Grosso S; Coppola G; Dontin SD; Gobbi G; Pruna D; Accorsi P; Verrotti A; Parisi P; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):641-5. PubMed ID: 24912730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rufinamide for refractory epilepsy in a pediatric and young adult population.
    Joseph JR; Schultz RJ; Wilfong AA
    Epilepsy Res; 2011 Jan; 93(1):87-9. PubMed ID: 21111576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome).
    von Stülpnagel C; Coppola G; Striano P; Müller A; Staudt M; Kluger G
    Eur J Paediatr Neurol; 2012 Sep; 16(5):459-63. PubMed ID: 22266062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy.
    Djuric M; Kravljanac R; Kovacevic G; Martic J
    Epileptic Disord; 2011 Mar; 13(1):22-6. PubMed ID: 21393091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures.
    Biton V; Krauss G; Vasquez-Santana B; Bibbiani F; Mann A; Perdomo C; Narurkar M
    Epilepsia; 2011 Feb; 52(2):234-42. PubMed ID: 20887365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and tolerability of rufinamide in children and young adults with Lennox-Gastaut syndrome: a single center study in Korea.
    Lee EH; Yum MS; Ko TS
    Clin Neurol Neurosurg; 2013 Jul; 115(7):926-9. PubMed ID: 23083943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy with myoclonic absences - favourable response to add-on rufinamide treatment in 3 cases.
    Häusler M; Kluger G; Nikanorova M
    Neuropediatrics; 2011 Feb; 42(1):28-9. PubMed ID: 21557146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.